Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Transatlantic Co-Operation Leads To Major Scientific CMOS (sCMOS) Technology Breakthrough
CMOS image sensor (CIS) technology stands on the brink of fulfilling its potential to become the global detector platform of choice for scientific photonics applications that require world class performance in the fields of sensitivity, speed, dynamic range, resolution, and field of view.
generic viagra online
Inflammatory Molecules Promote Liver Scarring
Scarring of the liver, which can progress to cirrhosis and/or cancer of the liver, is caused by persistent liver damage, such as occurs in those with untreated hepatitis C or alcoholism. Although such scarring (fibrosis) develops in an inflammatory environment, the role of inflammatory molecules has not been well defined. However, a team of researchers at Columbia University, New York, and UCSD, La Jolla, has established that the proteins CCR1 and CCR5 and the soluble inflammatory molecules that bind to them promote the development of liver fibrosis in mice.
News of the day
International Health Organizations Urge More Funding For Yellow Fever Vaccine Stockpile
The International Coordinating Group (ICG) on Yellow Fever Vaccine Provision is warning that the global emergency stockpile of yellow fever vaccine for the world"s most vulnerable populations in Africa is under threat.
Diagnostics

DART Trial Finds HIV Therapy Could Be Given Safely Without Routine Laboratory Tests To Save More Lives In Africa

Imperial College London Consistently rated amongst the world"s best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 13,000 students and 6,000 staff of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture. Since its foundation in 1907, Imperial"s contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve health in the UK and globally, tackle climate change and develop clean and sustainable s of energy. Website: http://www.imperial.ac.uk About The Department for International Development The Department for International Development (DFID) is the part of the UK government that manages Britain"s aid to poor countries and works to get rid of extreme poverty. It works in 150 countries and has 2,600 staff, half of whom work abroad. In 2007/08, DFID spent ÷£5.3 billion on aid to poorer countries and its budget will increase to ÷£7.9 billion by 2010/11. By 2013, the government has pledged to increase DFID"s aid to the equivalent of 0.7% of the UK"s gross national income, from 0.36% in 2007/08. DFID works with governments of developing countries, charities, businesses and international bodies, including the World Bank, the UN agencies and the European Commission, with the aim of reaching the Millennium Development Goals (MDGs) - international targets agreed by the United Nations (UN) to halve world poverty by 2015. About Gilead Sciences Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company"s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. About Boehringer Ingelheim The Boehringer Ingelheim group is one of the world"s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 138 affiliates in 47 countries and 41,300 employees. Since it was founded in 1885, the independent, family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. In 2008, Boehringer Ingelheim posted net sales of 11.6 billion euro while spending one fifth of net sales in its largest business segment Prescription Medicines on research and development.For more information please visit http://www.boehringer-ingelheim.com Medical Research Council

Pages: 1 [2] 


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009